We have investigated cell growth dynamics and cyclins B1 and E expression in cell lines derived from mycosis fungoides (MyLa), Sézary syndrome (SeAx), and CD30 + lymphoproliferative diseases (Mac1, Mac2a, JK). Mac1 and Mac2a had the highest growth rate (doubling time 18-28 h, >90% cycling cells) whereas SeAx was proliferating slowly (doubling time 55 h, approximately 35% cycling cells). Expression of cyclin B1 correlated positively with doubling time whereas expression of cyclin E was unscheduled and constant across the investigated cell lines. All cell lines exhibited high expression of PCNA. Thus, we concluded that cyclin B1 could be used for rapid screening of cell proliferation in malignant lymphocytes derived from cutaneous Tcell lymphoma.
Introduction
Cutaneous T-cell lymphomas (CTCLs) belong to the extra-nodal lymphomas arising primarily in the skin. 1 Common types of CTCLs (mycosis fungoides, Sézary's syndrome, and CD30 + lympho-proliferative diseases) are lowgrade neoplasias presenting a chronic, relapsing course. Curative treatments are not available, but CTCLs are responsive to ionizing radiation and PUVA (psoralen ultraviolet A therapy) in the early stages. Development of new medications for the advanced disease is hampered by a lack of suitable animal models, and cell lines have been used for the screening of new compounds. The most commonly used cell lines have been MyLa 2 and SeAx 3 derived from mycosis fungoides and Sézary syndrome, respectively, and Mac1, Mac2a, 4 or JK 5 obtained from patients with CD30 + lympho-proliferative diseases.
In this study we investigated growth dynamics and cell cycle characteristics in these cell lines. Particularly, we focused on the cell cycle distribution and expression of cyclins B1 and E, which are the key regulators of proliferation via activation of the cyclin-dependent kinases. Cyclin expression takes place at specific and well-defined points of the cell cycle; 6 however, in cancer cells unscheduled cyclin expression may be observed.
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Results and Discussion
The proliferation rate of neoplastic cells often reflects their degree of malignancy. In this study we analyzed the growth dynamics of five CTCL cell lines and the expression pattern of cell cycle regulators.
The time required for cell population doubling differed significantly between cell lines tested ( Figure 1 Cyclin B1 is an essential G2 cyclin necessary for CDK1 activation and cell entrance into the M phase. Its accumulation begins in the late S phase, reaches the maximal level as the cell enters mitosis, and is degraded rapidly at the beginning of anaphase. An altered expression pattern was observed in several neoplastic cell lines. For example, cyclin B1 has been detected in the G1 phase in HL-60 (leukemic), Hs578T, and T-47D (derived from breast carcin oma) cells. 6 We did not observe this phenomenon in any of the cell lines we tested. The cyclin B1 expression was perfectly scheduled, although the expression level differed among the cell lines tested and tended to be highest in the most rapidly proliferating cells (Figure 2 ). In contrast, the cyclin E pattern was similar in all cell lines. This factor is essential for cell entrance into the S phase, and therefore it is predominantly expressed in the G1 phase and decreases in the S and G2/M phases. However, we observed that a proportion of S and G2/M cells remained cyclin E positive (Figure 2 ). This phenomenon represents unscheduled cyclin E expression and has been described before in leukemic cell lines, namely Jurkat, K562, and U937. 8 PCNA, a subunit of DNA polymerase ∂, is a marker for growing cells. Its content increases in the late G1, peaks in the S, and decreases in the G2/M phase. 9 In the case of all CTCL cell lines tested, >90% of cells were PCNA positive, regardless of the growth rate of the cells.
We concluded that the cyclin B1 expression is normal in CTCL cell lines and the level of expression roughly correlated with growth rate. In contrast, cyclin E expression is unscheduled and constant in the cell lines we tested. Furthermore, PCNA is not useful as a marker of proliferation rate. 
